acetic acid has been researched along with Cirrhosis, Liver in 15 studies
Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center." | 9.11 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)." | 9.10 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000." | 6.71 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective locoregional therapies for hepatocellular carcinoma (HCC)." | 5.11 | Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center." | 5.11 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)." | 5.10 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000." | 2.71 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "Hepatocellular carcinoma is in 90% of cases associated with cirrhosis and to preserve liver function while destroying the tumor is a main issue in these patients justifying the development of local percutaneous ablative therapies." | 2.44 | Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments. ( Beaugrand, M; Seror, O, 2007) |
| "Liver fibrosis is a worldwide clinical issue." | 1.56 | Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio. ( Hao, M; Lu, T; Mao, C; Mao, J; Su, D; Wang, Q; Xie, H; Yu, M; Zhang, J, 2020) |
| "The immunological liver fibrosis model was prepared through intraperitoneal injection with porcine serum 0." | 1.46 | [Effects of Curcumae Rhizoma/vinegar-processed Curcumae Rhizoma on immune hepatic fibrosis, proliferation of HSC-T6 and expression of α-SMA and Procollagen I]. ( Gu, W; Hao, M; Li, L; Lu, TL; Mao, CQ; Song, Y; Wang, QH; Zhang, J, 2017) |
| "In the HFHC model of NAFLD, manipulation of dietary AGEs modulates liver injury, inflammation, and liver fibrosis via a RAGE dependent pathway." | 1.43 | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. ( Andrikopoulos, S; Angus, PW; Brown, BE; Davies, MJ; Forbes, JM; Furness, JB; Herath, CB; Jia, Z; Leung, C; Rivera, LR, 2016) |
| "Twelve patients with liver cirrhosis and an intrahepatic portosystemic shunt (TIPSS) were studied." | 1.36 | Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them? ( Bloemen, JG; Buurman, WA; Dejong, CH; Jalan, R; Olde Damink, SW; Venema, K, 2010) |
| "In patients with liver cirrhosis, propionate rose from a basal value of 6." | 1.27 | Systemic availability of propionate and acetate in liver cirrhosis. ( Joeres, R; Kasper, H; Richter, E; Richter, F; Scheppach, W, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Vuyyuru, SK | 1 |
| Singh, AD | 1 |
| Gamanagatti, SR | 1 |
| Rout, G | 1 |
| Gunjan, D | 1 |
| Lai, LY | 1 |
| Huang, MP | 1 |
| Su, S | 1 |
| Shu, J | 1 |
| Chen, Y | 1 |
| Liao, W | 1 |
| Zhu, Z | 1 |
| Chen, J | 1 |
| Yang, Q | 1 |
| Zheng, Y | 1 |
| Zhang, X | 1 |
| Limsila, B | 1 |
| Lu, M | 1 |
| Fu, S | 1 |
| Li, R | 1 |
| Zhang, J | 2 |
| Song, Y | 1 |
| Wang, QH | 1 |
| Li, L | 1 |
| Gu, W | 1 |
| Hao, M | 2 |
| Lu, TL | 1 |
| Mao, CQ | 1 |
| Rahimi, N | 1 |
| Hassanipour, M | 1 |
| Allahabadi, NS | 1 |
| Sabbaghziarani, F | 1 |
| Yazdanparast, M | 1 |
| Dehpour, A | 1 |
| Xie, H | 1 |
| Su, D | 1 |
| Mao, J | 1 |
| Wang, Q | 1 |
| Yu, M | 1 |
| Mao, C | 1 |
| Lu, T | 1 |
| Leung, C | 1 |
| Herath, CB | 1 |
| Jia, Z | 1 |
| Andrikopoulos, S | 1 |
| Brown, BE | 1 |
| Davies, MJ | 1 |
| Rivera, LR | 1 |
| Furness, JB | 1 |
| Forbes, JM | 1 |
| Angus, PW | 1 |
| Bloemen, JG | 1 |
| Olde Damink, SW | 1 |
| Venema, K | 1 |
| Buurman, WA | 1 |
| Jalan, R | 1 |
| Dejong, CH | 1 |
| Huo, TI | 2 |
| Huang, YH | 2 |
| Wu, JC | 2 |
| Lee, PC | 2 |
| Chang, FY | 2 |
| Lee, SD | 2 |
| LLOYD, HM | 1 |
| POWELL, LW | 1 |
| THOMAS, MJ | 1 |
| Fartoux, L | 1 |
| Arrive, L | 1 |
| Andreani, T | 1 |
| Serfaty, L | 1 |
| Chazouillères, O | 1 |
| Tubiana, JM | 1 |
| Poupon, R | 1 |
| Rosmorduc, O | 1 |
| Beaugrand, M | 1 |
| Seror, O | 1 |
| Scheppach, W | 1 |
| Richter, F | 1 |
| Joeres, R | 1 |
| Richter, E | 1 |
| Kasper, H | 1 |
| Herrmann, DB | 1 |
| Herz, R | 1 |
| Fröhlich, J | 1 |
2 reviews available for acetic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Liver Fibrosis Staging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid-enhanced: A Systematic Review and Meta-analysis.
Topics: Acetic Acid; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Liver Cirrhosis; Polyamines; Rubia | 2021 |
Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Ethanol; Human | 2007 |
4 trials available for acetic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
Topics: Acetic Acid; Adult; Biopsy; Blood Coagulation Disorders; Blood Component Transfusion; Chemoembolizat | 2020 |
Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug | 2003 |
Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeut | 2004 |
Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Feasi | 2005 |
9 other studies available for acetic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Essential oil from the raw and vinegar-processed
Topics: Acetic Acid; Animals; Body Weight; Collagen; Curcuma; Drugs, Chinese Herbal; Liver; Liver Cirrhosis; | 2021 |
[Effects of Curcumae Rhizoma/vinegar-processed Curcumae Rhizoma on immune hepatic fibrosis, proliferation of HSC-T6 and expression of α-SMA and Procollagen I].
Topics: Acetic Acid; Actins; Animals; Cell Line; Cell Proliferation; Curcuma; Drugs, Chinese Herbal; Hepatic | 2017 |
Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems.
Topics: Acetic Acid; Analgesics, Opioid; Animals; Bile Ducts; Enzyme Inhibitors; Intestinal Mucosa; Intestin | 2018 |
Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio.
Topics: Acetic Acid; Animals; Cell Line; Curcuma; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; | 2020 |
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
Topics: Acetic Acid; Animals; Cholesterol; Diet, High-Fat; Disease Progression; Fatty Liver; Fructose; Glyca | 2016 |
Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them?
Topics: Acetic Acid; Adult; Aged; Body Mass Index; Butyric Acid; Fatty Acids, Volatile; Female; Femoral Arte | 2010 |
IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID.
Topics: Acetic Acid; Biopsy; Blood Chemical Analysis; Chelating Agents; Diabetes Mellitus; Female; Genetics, | 1964 |
Systemic availability of propionate and acetate in liver cirrhosis.
Topics: Acetates; Acetic Acid; Duodenum; Fatty Acids, Volatile; Female; Humans; Liver Cirrhosis; Male; Middl | 1988 |
Role of gastrointestinal tract and liver in acetate metabolism in rat and man.
Topics: Acetates; Acetic Acid; Adult; Animals; Biological Transport, Active; Digestive System; Female; Homeo | 1985 |